40 Papers
122 Citations
M. Borgarelli is an academic researcher from Virginia–Maryland Regional College of Veterinary Medicine. The author has contributed to research in topics: Medicine & Mitral valve. The author has an hindex of 16, co-authored 37 publications. Previous affiliations of M. Borgarelli include Kansas State University.
Chat about Author
Papers
Survival Characteristics and Prognostic Variables of Dogs with Mitral Regurgitation Attributable to Myxomatous Valve Disease
M. Borgarelli,P. Savarino,S. Crosara,Roberto A. Santilli,D. Chiavegato,M. Poggi,Claudio Bellino,G. La Rosa,Renato Zanatta,Jens Häggström,Alberto Tarducci +10 more
TL;DR: Some clinical variables in chronic mitral valve disease can identify dogs at a higher risk of death; these variables might be useful to identify individuals that need more frequent monitoring or therapeutic intervention.
354
Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
Jens Häggström,Adrian Boswood,Michael R. O'Grady,Olaf Jöns,Sarah Smith,Simon Swift,M. Borgarelli,B. Gavaghan,Jan-Gerd Kresken,M. Patteson,B. Åblad,Claudio Bussadori,Tony M. Glaus,A. Kovacevic,M. Rapp,Roberto A. Santilli,Anna Tidholm,A. Eriksson,M.C. Belanger,M. Deinert,C.J.L. Little,Clarence Kvart,Anne French,M. Ronn-Landbo,Gerhard Wess,A.V. Eggertsdottir,M.L. O'Sullivan,Matthias Schneider,Christophe W. Lombard,Joanna Dukes-McEwan,Ruth Willis,A. Louvet,Rocky DiFruscia +32 more
TL;DR: Pimobendan plus conventional therapy prolongs time to sudden death, euthanasia for cardiac reasons, or treatment failure in dogs with CHF caused by MMVD compared with benazeprilplus conventional therapy.
307
ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs
Carol R. Reinero,Lance C. Visser,Heidi B. Kellihan,Isabelle Masseau,Elizabeth A. Rozanski,Cécile Clercx,Kurt J. Williams,Jonathan A Abbott,M. Borgarelli,Brian A. Scansen +9 more
TL;DR: Comprehensive evaluation including consideration of signalment, clinical signs, echocardiographic parameters, and results of other diagnostic tests supports the diagnosis of PH and allows identification of associated underlying conditions.
Historical review, epidemiology and natural history of degenerative mitral valve disease.
M. Borgarelli,James W. Buchanan +1 more
TL;DR: An historical perspective of the disease is presented and the most updated data on epidemiology and natural history of MMVD in dogs is reviewed.
208
Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease.
M. Borgarelli,Jonathan A. Abbott,L. Braz-Ruivo,D. Chiavegato,S. Crosara,Kenneth E. Lamb,Ingrid Ljungvall,M. Poggi,R.A. Santilli,Jens Häggström +9 more
TL;DR: In dogs with MMVD, moderate to severe PH worsens outcome and remained significant predictors of worse outcome in the multivariate analysis.
131